Clinical Trials Directory

Trials / Completed

CompletedNCT01212861

Surgical Treatment of Refractory Open Angle Glaucoma

Surgical Treatment of Refractory Open Angle Glaucoma - A Prospective, Open-Label, Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
4 (actual)
Sponsor
iScience Interventional Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to evaluate the safety, efficacy, and performance of the Suprachoroidal Dissection Instrument in creating a fistula between Schlemm's canal and the suprachoroidal space in refractory, open angle glaucoma subjects.

Detailed description

The Suprachoroidal Dissection Instrument (SDI) is a manually operated surgical instrument designed for use within Schlemm's canal. The instrument can access Schlemm's canal through a small ab-externo dissection, allowing use in eyes with scarring due to previous surgery or trauma.

Conditions

Interventions

TypeNameDescription
DEVICESuprachoroidal Dissection Instrument (SDI)The Suprachoroidal Dissection Instrument (SDI) is a manually operated, non-powered, re-usable ophthalmic surgical instrument. The SDI is designed to enter a surgically exposed Schlemm's canal and be advanced up to 90 degrees around the canal from the entry site.

Timeline

Start date
2010-08-01
Primary completion
2012-05-01
Completion
2012-05-01
First posted
2010-10-01
Last updated
2012-09-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01212861. Inclusion in this directory is not an endorsement.